Last updated on February 2018

Effect and Efficacy of Xpedition /Alpine Everolimus-eluting Stent for Coronary Atherosclerosis

Brief description of study

The objectives of this study are

  1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Xience Xpedition/Alpine stent
  2. To evaulate the long-term efficacy and safety of coronary stenting with the Xience Xpedition/Alpine stent
  3. To compare the long-term efficacy and safety of coronary stenting between the Xience Xpedition/Alpine stent and other contemporary drug-eluting stents which had established their own registry

Detailed Study Description

Secondary endpoints of this study are

Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3 years(very-late) after index PCI

Target vessl failure

Composite rate of cardiac death and any MI, 3 years

Composite rate of all death and any MI

Composite rate of all death, any MI, and any repeat revascularization

Compliance and therapy interruptions with prescribed adjunctive antiplatelet therapy

Clinical Study Identifier: NCT02845804

Find a site near you

Start Over